美国生物盾牌计划实施成效评析OA
Effectiveness of the Project BioShield in the United States
生物盾牌计划是美国的三大生物计划之一,旨在加速化学、生物、放射与核(CBRN)医疗对策的研究、开发和采购.该文介绍了这一计划的历史背景、管理机构、目标、经费和研发产品,重点分析了针对丝状病毒、痘病毒等病原体的产品研发情况,总结了其在运行机制、经费支撑,以及产品应对等方面的做法和特征,以供参考.
The Project BioShield is one of the three major biological programs in the United States,which is intended to accelerate the research,development,procurement,and availability of effective medical countermeasures against chemical,biological,radiological,and nuclear(CBRN)agents.This article analyzes the historical background,organizations of management,objectives,funding and products under development within the Project BioShield in general and the research and development of pathogen products such as filamentous virus and poxvirus in particular.What we can learn from the operational mechanisms,financing,and responses to products is also summarized in order to provide references for related research in China.
陈婷;祖勉;李丽娟
军事科学院军事医学研究院,北京 100850军事科学院军事医学研究院,北京 100850军事科学院军事医学研究院,北京 100850
社会科学
生物盾牌计划生物安全疫苗药物
Project BioShieldbiosafetyvaccinesdrugs
《军事医学》 2026 (2)
119-123,5
评论